Boluwatife OLU Afolabi

Dr. Boluwatife OLU Afolabi

Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, Minnesota, USA
+1
orcid
Head and Neck Cancer Researcher

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2026 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AAAbiodun Adegbesan
Abiodun Adegbesan
AAAdewunmi Akingbola
Adewunmi Akingbola
Samuel TundealaoSamuel Tundealao
Samuel Tundealao
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
SAStephen Oluwatimilehin Adekoya
Stephen Oluwatimilehin Adekoya
JCJoel Chuku
Joel Chuku

12 January 2025 in ScienceOpen Preprints
Verified
Preprint
Open access
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
KYKatrina Yershova
Katrina Yershova
PVPeter W Villalta
Peter W Villalta
ISIrina Stepanov
Irina Stepanov
We investigated the chemical composition of areca nut and gutkha products, which are commonly chewed in South and Southeast Asia. While these products are known to be addictive and carcinogenic, causing oral lesions and cancers, the specific chemical compounds responsible remain poorly understood. The study identified 149 unique compounds in the tested products, with 142 being newly discovered and potentially specific to areca nut-containing products. Seven compounds were previously found in smokeless tobacco. We arestillevaluating the toxicity profiles of these newly identified compounds and planto expand their analysis using gas chromatography with HRMS. Our findings aim to create a comprehensive library of toxicants and carcinogens, which will help understand the mechanisms behind these products’ harmful effects. This knowledge is expected to inform regulatory measures and public health education efforts to reduce consumption and decrease oral and pharyngeal cancer rates in Asian countries and immigrant communities in America.

28 February 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
TWTorojah M Williams
Torojah M Williams
Oral cancer remains one of the deadliest malignancies with more than half of late-stage patients dying within five years of diagnosis globally. Late presentation before initial diagnosis is a principal driver of poor outcomes for the disease. Artificial intelligence (AI), particularly deep learning systems, has emerged as a promising tool to improve the sensitivity and timeliness of oral cancer detection. This narrative review examines the current state of AI-assisted oral cancer diagnosis, evaluating the performance of image-based approaches [including convolutional neural networks (CNNs) applied to clinical photographs, histopathological slides, and cytology workflows] and critically analyzes where these systems fall short. Of note is the fact that AI models are functionally blind to submucosal and early infiltrating lesions without visible surface change, and their detection of high-grade epithelial dysplasia remains poor. Model generalizability across institutions is further compromised by the absence of large-scale standardized oral cancer image repositories. This review argues that the next frontier must shift from morphology-based learning to biologically informed AI [specifically through multiomics integration, tumor microenvironment characterization, and molecular imaging biomarkers] in order to detect oral cancer earlier and more reliably.

4 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
TFTitilayomi Faulkner
Titilayomi Faulkner
BIBlessing Ikubaje
Blessing Ikubaje
DODeborah Odeyemi
Deborah Odeyemi
IOIyanuoluwa Odole
Iyanuoluwa Odole
IOIbukunoluwa Olujimi
Ibukunoluwa Olujimi
Background: Cervicofacial necrotizing fasciitis (CNF) is a rare but life-threatening soft tissue infection in the head and neck region of the body, characterized by rapid progression and high mortality rates. Limited comprehensive data exist on its epidemiology and management across the African continent. Objective: To systematically review the hospital prevalence, etiological factors, management strategies, and clinical outcomes of cervicofacial necrotizing fasciitis in Africa. Methods: A systematic review of published studies on cervicofacial necrotizing fasciitis from African countries was conducted. Database searches were performed using keywords including "cervicofacial necrotizing fasciitis," "prevalence," "etiology," "management," and "outcome." Studies conducted in Africa that specifically focused on cervicofacial necrotizing fasciitis were included. Data were extracted and analyzed using SPSS version 20. Results: Seventeen studies encompassing 333 patients from six African countries were included. The mean age in the studies was 41.86 ± 17.99 years with a male predominance (53.15%). Odontogenic infections accounted for 89.1% of cases, with mandibular teeth involvement in 70.3% of cases. The submandibular region was the most affected anatomical site (36.6%). Diabetes mellitus was the most prevalent comorbidity (55.8% of patients with comorbidities). Streptococcus species were the most frequently isolated organisms (40.7%). Mean hospital stay was 23.2 ± 13.3 days, with a mean presentation delay of 15.39 ± 11.9 days. The overall mortality rate was 4.8%, with sepsis-related deaths occurring in 11.6% of patients with complications. Conclusion: Cervicofacial necrotizing fasciitis in Africa predominantly affects middle-aged males and is primarily odontogenic in origin. Late presentation remains a significant challenge. Early recognition, prompt surgical debridement, and broad-spectrum antibiotic therapy are essential for favorable outcomes. Enhanced public health education regarding dental hygiene and timely management of odontogenic infections is crucial.

30 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
Perineural invasion (PNI) is associated with poor outcomes in head and neck squamous cell carcinoma (HNSCC), yet neural invasion is seldom the outcome around which preclinical models are designed. Perineural infiltration has been observed in orthotopic tumors, but its occurrence alone does not establish whether a model can reproducibly measure nerve entry, extension along a nerve, or response to treatment. In this paper, the criteria for developing PNI-focused models are proposed, by which these outcomes can be distinguished from primary-tumor growth. Some recent studies provide two useful starting points: HO-1-u-1 tongue xenografts exhibit nerve-directed invasion, while direct infraorbital-nerve inoculation of murine oral cancer cells reproduces neural injury, nociceptive responses and impaired oral function. The former permits investigation of invasion from a mucosal tumor; the latter bypasses nerve entry and permits study of established neural disease. Model selection should therefore incorporate this experimental distinction while validation should require prespecified pathological definition, blinded and reproducible sampling, and analysis of neural involvement alongside tumor burden. Imaging and functional measurements should also be tested against histology, and the host immune context should match the mechanism or therapy under investigation. Establishing these measures would allow studies [and scientists] to determine whether an intervention prevents nerve entry, restricts neural spread or preserves function, and whether those effects extend beyond a reduction in tumor size.

25 June 2025
Verified
Preprint
Open access
PDF file
Boluwatife OLU AfolabiBoluwatife OLU Afolabi
Boluwatife OLU Afolabi
This protocol details a streamlined method for extracting high-quality total RNA from cultured adherent epithelial cancer cells using the Zymo Quick-RNA Miniprep Kit. The procedure incorporates direct cell lysis in the culture plate and an efficient in-column DNase I digestion step, yielding purified RNA suitable for sensitive downstream applications such as RT-qPCR and RNA sequencing.